Clinically effective monoclonal antibody 3F8 mediates nonoxidative lysis of human neuroectodermal tumor cells by polymorphonuclear leukocytes.
Brian H. Kushner(Memorial Sloan Kettering Cancer Center), N K Cheung(Memorial Sloan Kettering Cancer Center)
PubMed
September 15, 1991
Cited by 48
Related Papers
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.
|Journal of Clinical Oncology|1987|417
Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant interleukin 2.
|PubMed|1990|156
Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor.
|The Journal of Experimental Medicine|1990|126